Fagron Sterile Services (FSS) Revenue and Competitors

Fagron Sterile Services (FSS) operates FDA-registered 503B Outsourcing Facilities that provide sterile preparations produced with state-of-the-art automation and industry-leading quality control systems. We specialize in Sterile-to-Sterile, API-to-Sterile, and Biologics, offering an expansive portfolio of preparations including IV admixtures, OR syringes, pain management, ophthalmics, dialysis, urology, and adjunct solutions. OUR STORY: Fagron is leading the future of compounding by optimizing and innovating personalized pharmaceutical care. Founded in 1990, in the Netherlands, Fagron engineered one of the largest quality networks, with certified auditors performing supplier qualifications, serving 34 countries, to provide superior products for more than 200,000+ customers worldwide. In doing so, Fagron has become one of the world's leading pharmaceutical companies dedicated to safe, quality, compounding. In 2010, Fagron entered the North American market. As part of the only vertically integrated pharmaceutical company dedicated to sterile compounding, our 503B facilities drive pharmaceutical outsourcing solutions on a comprehensive level to meet customer needs across the continuum of care. As a forward-thinking pharmaceutical supplier, Fagron recognized the opportunity to serve our customers better by acquiring JCB Laboratories, in December, 2013. JCB has been at the forefront of shaping industry standards in sterile preparations for nearly two decades, and was one of the first companies in the country to register with the FDA. Building off JCB's experience, Fagron built FSS, our state-of-the-art manufacturing facility, because we believe in the need for regulated sterile preparations. We offer significant capabilities in research, development, manufacturing, and distribution. Choose Quality. Choose Consistency. Choose Fagron Sterile Services, A Solution You Can Rely On!